Dr. Sidlow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 East 66th Street
Floors 1 - 4
New York, NY 10065
Summary
- I am a board-certified internal medicine specialist whose interest is in the care of cancer patients: co-management of complex patients undergoing chemotherapy, radiotherapy, and surgery; long term management of cancer survivors; management of patients at high risk for cancer (i.e. carriers of germline mutations; post-cancer treatment patients); preventive cardiology in patients with clonal hematopoesis.
Education & Training
- City of HopeCancer Genomic Risk, 2020 - 2021
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1998
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
- NY State Medical License 1996 - 2026
- CT State Medical License 2023 - 2025
- NJ State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- City of HopeCancer Genomics Risk Assessment
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 2584 citationsImmune-Related Adverse Events Associated with Immune Checkpoint BlockadeMichael A. Postow, Robert Sidlow, Matthew D. Hellmann
The New England Journal of Medicine. 2018-01-10 - 137 citationsClonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.Peter Libby, Robert Sidlow, Amy E. Lin, Dipti Gupta, Lee W. Jones
Journal of the American College of Cardiology. 2019-07-30 - 35 citationsThe Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic.Kelly L. Bolton, Ahmet Zehir, Ryan Ptashkin, Minal Patel, Dipti Gupta
Hematology/oncology Clinics of North America. 2020-01-18
Journal Articles
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorRobert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
Authored Content
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020
Press Mentions
- Hereditary Cancers Aren’t Just a Women’s Problem. Jewish Men Need to Take Precautions TooNovember 28th, 2022
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: